Contents
Key findings
- 1Melanotan II works - it activates the MC1R pigment receptor and darkens skin - but "it works" is not the same as "it is safe."
- 2It is not approved as a drug or cosmetic anywhere in the world; products sold online are unregulated and of unknown quality.
- 3Published case reports link it to new moles, rapidly changing moles, and several reported melanomas, though those patients often had other skin-cancer risk factors too.
- 4Because it also hits other receptors, reported side effects include nausea, flushing, prolonged erections, darkening of nails, and rare severe reactions.
- 5The honest summary is a genuine effect with a poorly-defined but real safety concern - which is exactly why regulators warn against it.
Evidence level
Melanotan II clearly does what it claims - it darkens skin by activating a pigment receptor. The safety picture comes mostly from case reports and reviews, which raise real concerns about changing moles and melanoma but cannot prove how large the risk is.
Regulatory status
Melanotan II is not approved as a medicine or cosmetic anywhere in the world, including by the FDA. It is sold online as an unregulated "tanning" injection or nasal spray.
Melanotan II is sold online as a shortcut to a tan - an injection or nasal spray that darkens your skin without the sun. Here is the honest version: it genuinely works, and that is exactly why it is worth taking seriously. Because "it works" and "it is safe" are two very different claims, and only one of them is true.
What it is and why it darkens skin
Melanotan II is a lab-made peptide that switches on a receptor in your skin called MC1R (the melanocortin-1 receptor). That receptor is the body's own control for melanin - the pigment that makes skin darker. Turn it up, and your skin produces more pigment and tans, even without much sun[2].
So unlike a lot of hyped peptides, this one is not snake oil - the tanning effect is real. The catch is everything around that effect.
It is approved nowhere
This is the part the "tan jab" sellers skip. Melanotan II is not approved as a medicine or a cosmetic anywhere in the world, including by the FDA[2]. It is not a regulated product - it is a research chemical sold for human use.
That means the vials and nasal sprays sold online have no quality control: you do not know the real dose, the purity, or what else is in them. Health regulators in multiple countries have specifically warned consumers against it.
The safety concerns that matter
MC1R - the receptor melanotan II activates - sits on the same cells (melanocytes) that can turn into melanoma, the most serious skin cancer. That is the core worry, and it is not hypothetical:
- Published case reports describe new moles, rapidly changing or darkening moles, and melanomas in people using melanotan II[1]. Many of those people had other risk factors too (fair skin, tanning-bed use, family history), so this does not prove melanotan II caused the cancers - but it is a real pattern that dermatologists take seriously.
- Just as important: darkening your moles can make skin cancer harder to spot early, because the warning signs (a mole changing color or size) are exactly what the drug does on purpose[2].
Because melanotan II also switches on other melanocortin receptors, it comes with a grab-bag of other reported effects: nausea and flushing (very common, especially at first), prolonged erections, darkening of the nails, and rarer severe reactions[2].
What people say versus what is known
Online, melanotan II is sold as a "safer tan" - no UV, no burning. The logic sounds reasonable and is exactly backwards. The evidence we have is a real drug effect wrapped around a poorly-defined but genuinely worrying safety signal, on a product no regulator has cleared. "No good safety data" is not the same as "safe" - it usually means no one has looked hard enough yet.
The bottom line
Melanotan II is the rare peptide that does exactly what the ads say - and that is the problem, not the reassurance. It darkens skin by dialing up the same cells that become melanoma, it can hide the early signs of that cancer, and it is approved and quality-controlled nowhere. A real effect on top of an unmeasured risk is not a good trade.
Where to go next
- Peptides for skin: what the evidence supports
- FDA-approved, off-label, investigational and unapproved peptides
- Peptide purity and contamination: reading a certificate of analysis
- Peptide safety hub
Frequently asked questions
- Does melanotan II actually work for tanning?
- Yes - that part is real. It activates the MC1R pigment receptor and makes skin produce more melanin, so skin darkens. The problem is not whether it works; it is whether it is safe, and it is not approved anywhere.
- Is melanotan II safe?
- There is no good safety data, which is itself the problem. Published case reports link it to changing moles and reported melanomas, and because it is unregulated, the products sold online are of unknown purity and dose.
- Is melanotan II FDA-approved?
- No. Melanotan II is not approved as a drug or a cosmetic by the FDA or by regulators anywhere in the world. It is sold illegally online as a 'tanning' injection or nasal spray.
- Can melanotan II cause skin cancer?
- It has not been proven to cause melanoma, but published case reports describe melanomas and rapidly changing moles in people using it, and it can make moles darker and harder to monitor - which is why dermatologists urge caution.
References
Numbered in order of first use. Study type is shown for every source; see our methodology for how we rank evidence.
- 1.
Melanoma associated with the use of melanotan-II Dermatology (PubMed 24355990), 2014.
Case report
Result: Reports melanoma occurring in association with melanotan-II use, adding to published concern that the drug may promote changes in moles and pigmented lesions that complicate melanoma detection.
↑ back to text - 2.
An overview of benefits and risks of chronic melanocortin-1 receptor activation Peer-reviewed review (NIH PMC11664455), 2024.
Review
Result: Reviews the effects of activating the melanocortin-1 receptor (the target of melanotan II), including pigmentation effects and the safety questions raised by chronic, unregulated activation.
↑ back to text
Review status: Editorially reviewed against primary sources. This article was fact-checked against the primary sources listed in the references by our editorial team, and it has not been reviewed by a licensed clinician. It is educational content, not medical advice. Read our editorial policy and methodology. Spotted an error? Tell us.
